Determination of the new aromatase inhibitor exemestane in biological fluids by automated high-performance liquid chromatography followed by radioimmunoassay

European Journal of Pharmaceutical Sciences

Volumn 4, Issue 6, 1996, Pages 331-340

  Persiani, S ^a,b   Broutin, F ^a   Cicioni, P ^a   Stefanini, P ^a   Strolin Benedetti, M ^a,b  

^a PFIZER INC   (United States)

^b Zambon Group SpA   (Italy)

Author keywords

Aromatase inhibitor; Combination of HPLC and RIA; Exemestane

Indexed keywords

AROMATASE INHIBITOR; EXEMESTANE;

AGED; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BODY FLUID; DRUG DETERMINATION; EXTRACTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; URINALYSIS; VOLUNTEER;

EID: 0030296542     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(96)00171-6     Document Type: Article

References (16)

1. 18 Columns. Ann. N.Y. Acad. Sci. 595, 251-259.
2. Breda, M., Pianezzola, E. and Strolin Benedetti, M. (1993) Determination of exemestane, a new aromatase inhibitor, in plasma by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 620, 225-231.
3. Buzzetti, F., Di Salle, E., Longo, A. and Briatico, G. (1993) Synthesis and aromatase inhibition by potential metabolites of exemestane (6-methylenandrosta-1,4-diene-3,17-dione). Steroids 58, 527-532.
4. Cocchiara, G., Allievi, C., Berardi, A., Zugnoni, P., Strolin Benedetti, M. and Dostert, P. (1994) Urinary metabolism of exemestane, a new aromatase inhibitor, in rat, dog, monkey and human volunteers. J. Endocrinol. Invest. 17, 78 (Suppl. 1-3).
5. Di Salle, E., Ornati, G., Giudici, D., Lassus, M., Evans, T.R.J. and Coombes, R.C. Exemestane (FCE 24304) a new steroidal aromatase inhibitor. (1992) J. Steroid Biochem. Mol. Biol. 43, 137-143.
6. Di Salle, E., Ornati, G., Paridaens, R., Coombes, R.C., Lobelle, J.P. and Zurlo, M.G. (1994) Preclinical and clinical pharmacology of the aromatase inhibitor exemestane (FCE 24304). J. Endocrinol. Invest. 17, 22 (Suppl. 1-3).
7. Evans, T.R., Di Salle, E., Ornati, G., Lassus, M., Strolin Benedetti, M., Pianezzola, E. and Coombes, C. (1992) Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in post-menopausal women. Cancer Res. 52, 5933-5939.
8. Grodin, J.M., Siiteri, P.K. and McDonald, P.B., (1973) Source of estrogen production in postmenopausal women J. Clin. Endocrinol. Metab. 36, 207-214.
9. Henderson, I.C. and Canellos, G.P. (1980) Cancer of the breast: the past decade (first of two parts). New Engl. J. Med. 302, 17-30.
10. Kirschner, M.A. (1979) The role of hormones in the development of human breast cancer. In: McGuire, W.L. (ed.), Breast Cancer 3: Advances in Research and Treatment, Current Topics. Plenum, New York, NY, pp. 199-226.
11. Allievi, C., Strolin Benedetti, M. and Dostert, P. (1995) Determination of plasmalevels of exemestane (FCE 24304), a new irreversible aromatase inhibitor, using liquid chromatography-thermospray mass spectrometry. J. Mass Spectrometry 30, 693-697.
12. Ryan, K.J. (1959) Biological aromatization of steroids. J. Biol. Chem. 234, 268-272.
13. Santen, R.J. (1987) Potential clinical role of new aromatase inhibitors. Steroids 50, 575-593.
14. Scatchard, G. (1949) The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51, 660-672.
15. Segaloff, A. (1978) Hormones and mammary carcinogens. In: McGuire, W.L. (ed.) Advances in Research and Treatment, Experimental Biology. Plenum, New York, NY, pp. 1-22.
16. United States Pharmacopoeia XXII (1990) US Pharmacopoeial Convention, Rockville, MD, USA. 621, 1566-1567.